Medications for Breast Neoplasms

121 results

  • anastrozole

    (Anastrozole Tablets)
    Upsher-Smith Laboratories, LLC
    Anastrozole is indicated for the adjuvant treatment of hormone receptor-positive early breast cancer in postmenopausal women, as well as for first-line and second-line treatments of locally advanced or metastatic breast cancer. It is effective following disease progression after tamoxifen therapy.

  • anastrozole

    (Anastrozole Tablets)
    AiPing Pharmaceutical Inc
    Anastrozole is indicated for the adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer, as well as for first-line and second-line treatment of locally advanced or metastatic breast cancer, particularly following disease progression after tamoxifen therapy.

  • anastrozole

    (Anastrozole)
    American Health Packaging
    Anastrozole tablets are indicated for adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer, first-line treatment of hormone receptor-positive or unknown locally advanced or metastatic breast cancer, and second-line treatment of advanced breast cancer following disease progression on tamoxifen therapy.

  • anastrozole

    (Anastrozole)
    Natco Pharma Limited
    Anastrozole tablets are indicated for adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer, as well as for first-line treatment of hormone receptor-positive or unknown locally advanced or metastatic breast cancer. It is also used as a second-line treatment for advanced breast cancer after tamoxifen therapy.

  • anastrozole

    (Anastrozole)
    Ascend Laboratories, LLC
    Anastrozole tablets are indicated for treating advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy. Responders to previous tamoxifen treatment are essential, as those with ER-negative disease or prior lack of response rarely benefit from anastrozole.

  • anastrozole

    (Anastrozole)
    Synthon Pharmaceuticals Inc
    Anastrozole Tablets are indicated for the adjuvant treatment of hormone receptor-positive early breast cancer in postmenopausal women, as well as for first-line treatment of locally advanced or metastatic breast cancer (hormone receptor-positive or unknown) and second-line treatment after tamoxifen therapy.

  • anastrozole

    (Anastrozole)
    NuCare Pharmaceuticals,Inc.
    Anastrozole tablets are indicated for adjuvant treatment of hormone receptor-positive early breast cancer in postmenopausal women, first-line treatment of locally advanced or metastatic breast cancer (hormone receptor-positive or unknown), and second-line treatment for advanced breast cancer after disease progression on tamoxifen.

  • anastrozole

    (Anastrozole)
    Ascend Laboratories, LLC
    Anastrozole tablets are indicated for advanced breast cancer treatment in postmenopausal women whose disease progressed after tamoxifen therapy. It is less effective in patients with ER-negative disease or those who did not respond to prior tamoxifen treatment.

  • anastrozole

    (Anastrozole)
    Boscogen, Inc.
    Anastrozole is indicated for treating advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy. It is less effective in patients with ER-negative disease or those who did not respond to earlier tamoxifen treatment.

  • anastrozole

    (Anastrozole)
    Stason Pharmaceuticals Inc
    Anastrozole is indicated for adjuvant treatment of hormone receptor-positive early breast cancer in postmenopausal women, first-line treatment for hormone receptor-positive or unknown locally advanced/metastatic breast cancer, and second-line treatment for advanced breast cancer following tamoxifen therapy in postmenopausal women.